IS5359A - Lyfjasamsetning með D-vítamíni og kalsíum, framleiðsla þeirra og notkun í meðferðarskyni - Google Patents

Lyfjasamsetning með D-vítamíni og kalsíum, framleiðsla þeirra og notkun í meðferðarskyni

Info

Publication number
IS5359A
IS5359A IS5359A IS5359A IS5359A IS 5359 A IS5359 A IS 5359A IS 5359 A IS5359 A IS 5359A IS 5359 A IS5359 A IS 5359A IS 5359 A IS5359 A IS 5359A
Authority
IS
Iceland
Prior art keywords
calcium
vitamin
pharmaceutical composition
preparation
therapeutic purposes
Prior art date
Application number
IS5359A
Other languages
English (en)
Inventor
Valleri Maurizio
Original Assignee
Menarini International Operations Luxembourg S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A. filed Critical Menarini International Operations Luxembourg S.A.
Publication of IS5359A publication Critical patent/IS5359A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5359A 1997-07-30 2000-01-24 Lyfjasamsetning með D-vítamíni og kalsíum, framleiðsla þeirra og notkun í meðferðarskyni IS5359A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
PCT/EP1998/004567 WO1999006051A1 (en) 1997-07-30 1998-07-21 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use

Publications (1)

Publication Number Publication Date
IS5359A true IS5359A (is) 2000-01-24

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5359A IS5359A (is) 1997-07-30 2000-01-24 Lyfjasamsetning með D-vítamíni og kalsíum, framleiðsla þeirra og notkun í meðferðarskyni

Country Status (28)

Country Link
US (1) US7067154B1 (is)
EP (1) EP0999843B1 (is)
JP (1) JP4497496B2 (is)
KR (1) KR100573421B1 (is)
AT (1) ATE271387T1 (is)
AU (1) AU8978198A (is)
BG (1) BG65044B1 (is)
BR (1) BR9810832B1 (is)
CA (1) CA2299420C (is)
CZ (1) CZ297670B6 (is)
DE (1) DE69825164D1 (is)
EA (1) EA002492B1 (is)
EE (1) EE04046B1 (is)
ES (1) ES2223135T3 (is)
HU (1) HU226112B1 (is)
ID (1) ID23504A (is)
IL (1) IL134268A0 (is)
IS (1) IS5359A (is)
IT (1) ITFI970184A1 (is)
NO (1) NO20000310D0 (is)
PL (1) PL189295B1 (is)
PT (1) PT999843E (is)
RS (1) RS49703B (is)
SI (1) SI0999843T1 (is)
SK (1) SK284873B6 (is)
TR (1) TR200000261T2 (is)
UA (1) UA61968C2 (is)
WO (1) WO1999006051A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
US10258576B2 (en) 2004-05-24 2019-04-16 Takeda As Particulate comprising a calcium-containing compound and a sugar alcohol
JP4996458B2 (ja) 2004-06-01 2012-08-08 ニコメド ファーマ エイエス 活性物質としてカルシウム含有化合物を含み、咀嚼し、舐め、飲み込むことのできる錠剤
EA013867B1 (ru) 2005-02-03 2010-08-30 Никомед Фарма Ас Способ получения гранулята, содержащего карбонат кальция
US8846088B2 (en) 2005-02-03 2014-09-30 Takeda Nycomed As Melt granulation of a composition containing a calcium-containing compound
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
CN102872157A (zh) 2005-12-07 2013-01-16 奈科明制药有限公司 预先压实的含钙组合物
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2587805C (en) 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
CA2742449C (en) 2008-11-17 2018-04-24 Takeda As Improved dissolution stability of calcium carbonate tablets
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
FI3787596T3 (fi) 2018-05-02 2025-09-29 Ferring Bv Parannettuja farmaseuttisia formulaatioita
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
EP4304569A1 (en) * 2021-03-12 2024-01-17 Nicoventures Trading Limited Oral products with self-emulsifying system
WO2025079114A1 (en) * 2023-10-13 2025-04-17 Vytals Wellbeing India Pvt. Ltd. A self-nano emulsifying drug formulation for cholecalciferol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (is) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
CA2080818A1 (en) * 1990-05-16 1991-11-17 Zbigniew Walaszek Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyerproliferative disorders
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
CA2299420C (en) 2009-04-21
YU3700A (sh) 2002-11-15
BR9810832B1 (pt) 2010-11-16
CZ2000199A3 (cs) 2000-05-17
US7067154B1 (en) 2006-06-27
JP4497496B2 (ja) 2010-07-07
HUP0100539A2 (hu) 2001-08-28
ID23504A (id) 2000-04-27
PL338237A1 (en) 2000-10-09
CZ297670B6 (cs) 2007-02-28
ITFI970184A1 (it) 1999-01-30
BR9810832A (pt) 2000-07-25
ATE271387T1 (de) 2004-08-15
EP0999843A1 (en) 2000-05-17
PL189295B1 (pl) 2005-07-29
IL134268A0 (en) 2001-04-30
EE04046B1 (et) 2003-06-16
NO20000310L (no) 2000-01-21
KR20010022319A (ko) 2001-03-15
BG65044B1 (bg) 2007-01-31
TR200000261T2 (tr) 2000-09-21
SI0999843T1 (en) 2005-02-28
HU226112B1 (en) 2008-04-28
NO20000310D0 (no) 2000-01-21
DE69825164D1 (de) 2004-08-26
PT999843E (pt) 2004-11-30
EE200000054A (et) 2000-10-16
BG104057A (en) 2000-07-31
RS49703B (sr) 2007-12-31
WO1999006051A1 (en) 1999-02-11
JP2001511453A (ja) 2001-08-14
SK802000A3 (en) 2000-07-11
EA002492B1 (ru) 2002-06-27
ES2223135T3 (es) 2005-02-16
HK1027751A1 (en) 2001-01-23
SK284873B6 (sk) 2006-01-05
AU8978198A (en) 1999-02-22
CA2299420A1 (en) 1999-02-11
EP0999843B1 (en) 2004-07-21
UA61968C2 (en) 2003-12-15
KR100573421B1 (ko) 2006-04-26
EA200000181A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
EE04046B1 (et) Vitamiini D ja kaltsiumit sisaldav ravimkoostis, selle valmistamine ja terapeutiline kasutamine
HUP9802448A3 (en) Inhibitors of platelet aggregation, preparation and use thereof and pharmaceutical compositions
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
EP0828485A4 (en) USE OF THE R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDANE, ITS SALTS AND COMPOSITIONS
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ID28598A (id) Komposisi-komposisi yang mengandung vitamin-vitamin yang dapat larut lemak
SE9802937D0 (sv) Novel compounds
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE68914700D1 (de) Polymere Zusammensetzungen und ihre Herstellung.
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
FI896003A7 (fi) Prourokinaasin johdannaiset, joilla on alhainen molekyylipaino, ja nii tä sisältävät farmaseuttiset koostumukset
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
KR900017599A (ko) 종양 치료용 약학 조성물
FR2772764B1 (fr) Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments
RU92015818A (ru) Способ для лечения энуреза
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
BR9806851A (pt) ComposiçÊes farmaceuticas e alimenticias que contêm bactérias de gênero acetobacter